NCT07280364Recruiting
Metabolomics in the Diagnosis and Treatment of Asthma in Children
Source: ClinicalTrials.gov · Last updated 28 Jan 2026
Brief summary (registry, in English)
The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is: • Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 1 Dec 2025
- Start date
- 13 Mar 2024
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Diseases
- Asthma
- NCT number
- NCT07280364
What you commit to
- Study type: Observational
- Planned participants: 100
- From 13 Mar 2024 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- concomitant severe somatic, metabolic, and endocrine diseases
Age
- age under 12 years
Other
- no established diagnosis of asthma
- patient's withdrawal of informed consent
Who the study is looking for
- Age from 12 to 17 years old
- Confirmed diagnosis of asthma
- Informed voluntary consent to participate in the study
Age in the registry: 12 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| I.M. Sechenov First Moscow State Medical University (Sechenov University) Coordinator of this site? Confirm its status | Moscow | Russia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.